IP No. 600258 The disclosure relates to a non-fermented composition having the ability to increase the formation of butyric acid in the colon comprising at least one cereal based fraction and at least one isolated pro biotic strain of Lactobacillus, wherein the at least one cereal based fraction is a barley fraction and is present in the non-fermented composition in the range of 40-100%weight. Also disclosed is A dry, non-fermented composition having the ability to increase the formation of butyric acid in the colon comprising at least one cereal based fraction and at least one isolated probiotic strain of Lactobacillus, wherein the at least one cereal based fraction is a barley fraction and said barley fraction is present in the non-fermented composition as brewer&rsquo；s spent grain and the at least one isolated strain of Lactobacillus is present in an amount of 106 - 1014 CFU/day, preferably 108 - 1012 CFU/day, more preferably 109 - 1011 CFU/day. Also disclosed is the use of the compositions in treatment of metabolic syndrome, ulcerative colitis, Crohns disease, Irritable bowel syndrome (lBS), or Inflammatory bowel disease (IBD). The disclosed composition can be used as or in: a medical food, a functional food, a dietary supplement, a nutritional product, a food, a food additive, cereals, muesli, breads, biscuits, cereals, health bars, spreads, drink, a beverage, a yoghurt, a juice or an ice cream
